ArticleBMC cancer2024

The impact of high-risk cytogenetic abnormalities in extramedullary multiple myeloma in the era of novel agents: insights from a multicenter study.

Dong Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.